ICUI Logo

ICU Medical, Inc. (ICUI) 

NASDAQ
Market Cap
$4.39B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
570 of 776
Rank in Industry
36 of 48

Largest Insider Buys in Sector

ICUI Stock Price History Chart

ICUI Stock Performance

About ICU Medical, Inc.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana …

Insider Activity of ICU Medical, Inc.

Over the last 12 months, insiders at ICU Medical, Inc. have bought $0 and sold $193.96M worth of ICU Medical, Inc. stock.

On average, over the past 5 years, insiders at ICU Medical, Inc. have bought $1.23M and sold $60.1M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 7,092 shares for transaction amount of $1.23M was made by LOPEZ GEORGE A () on 2022‑05‑12.

List of Insider Buy and Sell Transactions, ICU Medical, Inc.

2024-11-01SaleChairman and CEO
12,000
0.0494%
$171.84$2.06M+0.69%
2024-10-01SaleChairman and CEO
12,000
0.0503%
$178.47$2.14M-0.23%
2024-09-03SaleChairman and CEO
12,000
0.0492%
$163.46$1.96M+8.55%
2024-08-30SaleVP, GM-Infusion Capital
2,502
0.0101%
$163.22$408,370+7.04%
2024-08-16SaleChairman and CEO
12,000
0.0516%
$156.04$1.87M-0.12%
2024-08-08SaleVP, General Counsel
2,050
0.0081%
$144.11$295,426+15.66%
2024-05-30SaleChief Operating Officer
12,539
0.0517%
$103.95$1.3M+56.71%
2024-05-16Saledirector
300
0.0012%
$104.95$31,484+46.62%
2024-05-10SaleChief Information Officer
2,000
0.0081%
$105.55$211,090+42.67%
2024-03-15SaleVP, GM-Infusion Capital
791
0.0033%
$98.27$77,733+19.17%
2024-03-14Saledirector
7,978
0.0333%
$101.87$812,741+18.03%
2024-03-12Saledirector
1,522
0.0063%
$101.51$154,497+15.20%
2024-03-11Saledirector
1,890
0.0079%
$104.22$196,968+11.98%
2024-03-08Saledirector
15,372
0.0643%
$105.94$1.63M+10.85%
2024-03-08SaleVP, General Counsel
3,300
0.0136%
$104.57$345,088+10.85%
2024-03-07Saledirector
18,954
0.0792%
$105.77$2M+9.52%
2024-03-04Saledirector
7,051
0.0292%
$106.79$752,993+6.21%
2024-03-04SaleChief Operating Officer
13,603
0.0565%
$107.19$1.46M+6.21%
2024-02-29SaleFormer 10% Owner
830,000
3.3087%
$106.08$88.04M+4.09%
2024-02-29SaleFormer 10% Owner
830,000
3.3087%
$106.08$88.04M+4.09%

Insider Historical Profitability

7.98%
LOPEZ GEORGE Adirector
877343
3.5919%
$179.639248+23.53%
Jain VivekChairman and CEO
104593
0.4282%
$179.63128+6.49%
SHERMAN RICHARD MDdirector
69199
0.2833%
$179.63116
SWINNEY ROBERT Sdirector
20816
0.0852%
$179.63134
BROWN JACKdirector
16813
0.0688%
$179.6313

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$278.48M10.652.59M+1.42%+$3.89M0.01
Janus Henderson$265.24M10.142.47M-5.59%-$15.72M0.13
The Vanguard Group$263.23M10.072.45M+0.49%+$1.29M0.01
Fuller & Thaler Asset Management, Inc.$164.71M6.31.53M+4.26%+$6.73M0.72
Wellington Management Company$148.01M5.661.38M-12.46%-$21.06M0.03
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.